Syncom Formulations (India) Ltd. (SYNCOMF): Syncom Formulations (India) Share Price Near 52-Week High After 11.42% Rise
- September 28, 2026
- Posted by: Chaitanya Auti
- Category: News
Syncom Formulations (India) Ltd. Share Price is at Rs 22.35, up 11.42% today, and trading close to its 52-week high with a market capitalisation of Rs 1,885.64 crore. The latest move places Syncom Formulations (India) Ltd. (SYNCOMF) among the notable stocks in news in the healthcare space.
Syncom Formulations (India) Ltd. Share Price is trading at Rs 22.35, up Rs 2.29 or 11.42% from the previous close of Rs 20.06, with a market capitalisation of Rs 1,885.64 crore. The move keeps the stock near its 52-week high and makes Syncom Formulations (India) Share Price a live search focus for investors tracking Syncom Formulations (India) Share Price Today and Syncom Formulations (India) Stock News.
Syncom Formulations (India) Share Price Today: Price Action Analysis
As of 28 September 2026 at 10:22 AM IST, Syncom Formulations (India) Ltd. Share Price has moved from the day’s open of Rs 20.06 to a high of Rs 23.44 and a low of Rs 20.06. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst. Even so, the stock is drawing attention because Syncom Formulations (India) Share Price is now close to its one-year high, and that matters for traders, long-term followers and readers searching Syncom Formulations (India) Share Price Today, Syncom Formulations (India) Share Price Live and Syncom Formulations (India) Latest News.
The broader context is simple: Syncom Formulations (India) Share Price is being watched because the move combines a sharp single-day gain with a yearly high setup in the healthcare sector. Univest continues to track Syncom Formulations (India) Share Price, Syncom Formulations (India) Stock News and Syncom Formulations (India) Share Price Update so readers can see the latest price action alongside valuation and sector comparisons.
| Metric | Value |
|---|---|
| Current Price | Rs 22.35 |
| Previous Close | Rs 20.06 |
| Today's Move | +Rs 2.29 (+11.42%) |
| Open | Rs 20.06 |
| High | Rs 23.44 |
| Low | Rs 20.06 |
| Market Capitalisation | Rs 1,885.64 crore |
Syncom Formulations (India) Ltd. (SYNCOMF) traded at Rs 22.35 versus the previous close of Rs 20.06, a rise of 11.42%. The stock opened at Rs 20.06, reached a high of Rs 23.44 and touched a low of Rs 20.06.
Syncom Formulations (India) Share Price today reflects a clean move above the previous close, with Rs 22.35 compared with Rs 20.06 yesterday. The stock added Rs 2.29 in a single move, and the day’s range stretched from Rs 20.06 to Rs 23.44. Because Syncom Formulations (India) Share Price is trading close to its 52-week high, the market is naturally treating this as an important Share Price Today update rather than a routine fluctuation.
The key point in Syncom Formulations (India) Share News is that the latest reading confirms proximity to the yearly high without claiming a new record. That distinction matters for anyone searching Syncom Formulations (India) Share Price, Syncom Formulations (India) Share Price Today or Syncom Formulations (India) Stock News Today. The stock also opened at Rs 20.06, matching the previous close, which makes the current move easier to read as a fresh intraday shift rather than a gap-led opening. For readers following 52 Week High Stocks in the Indian Stock Market, this is one of the cleaner price action updates in today’s Market News.
Syncom Formulations (India) Share Price is therefore in focus not because of a stated trigger, but because the price behaviour itself is notable. The stock has moved into a zone that often attracts more headline attention in Stocks in News, Top Gainers Today and Share Market Today searches. The next natural question is whether the latest share price action aligns with the company’s fundamentals and sector positioning, which is where Syncom Formulations (India) Fundamental Analysis becomes important.
Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,885.64 crore |
| P/E Ratio | 22.05x |
| P/B Ratio | 4.29x |
| ROE | 20.19% |
| ROCE | 26.8% |
| EPS | Rs 0.91 |
| Book Value Per Share | Rs 4.68 |
| Dividend Yield | 0.5% |
Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P/E 22.05x, P/B 4.29x, ROE 20.19%, ROCE 26.8%. These figures provide context only and are not a buy or sell signal.
Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1885.64 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 22.05x, P/B at 4.29x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.5%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.81x, median ROE of 11.43%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 22.05x |
| Benchmark Median P/E | 27.81x |
| Benchmark Average P/E | 41.21x |
| Benchmark P/E Range | 0x to 735.85x |
| Company P/B Ratio | 4.29x |
| Benchmark Median P/B | 2.83x |
| Company ROE | 20.19% |
| Benchmark Median ROE | 11.43% |
| Company ROCE | 26.8% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 1,885.64 crore |
| Benchmark Median Market Cap | Rs 722.23 crore |
Syncom Formulations (India) Ltd. (SYNCOMF) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 22.05x, which is below the benchmark median of 27.81x, a difference of -20.71%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.43%, a difference of +76.64%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.1%, a difference of +104.58%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Hester Biosciences Ltd. | HESTERBIO | 1,857.9 | 13.64 | 4.08 | 17.05 | 16.21 |
| NGL Fine-Chem Ltd. | NGLFINE | 1,800.49 | 31.48 | 5.18 | 15.74 | 16.88 |
| ANLON HEALTHCARE LIMITED | AHCL | 1,680.12 | 58.92 | 5.76 | 18.73 | 21.98 |
| Accent Microcell Ltd. | ACCENTMIC | 1,618.9 | 36.91 | 5.88 | 18.65 | 24.88 |
| Jagsonpal Pharmaceuticals Ltd. | JAGSNPHARM | 1,601.45 | 35.22 | 6.95 | 18.19 | 22.69 |
Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 22.05x compared with the displayed peer median of 35.22x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.19% compares with a peer median of 18.19% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 21.98%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,885.64 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Syncom Formulations (India)
- Syncom Formulations (India) Share Price is Rs 22.35, up 11.42% from the previous close of Rs 20.06.
- The stock is trading close to its 52-week high, making Syncom Formulations (India) Share Price a notable yearly high update.
- Market capitalisation stands at Rs 1,885.64 crore, which is part of the current Syncom Formulations (India) Share Price story.
- P/E is 22.05, P/B is 4.29, ROE is 20.19% and ROCE is 26.8% in the latest Syncom Formulations (India) Fundamental Analysis.
- In the peer set, Syncom Formulations (India) Share Price is above several companies on ROE and ROCE while remaining below some peers on P/E.
About Syncom Formulations (India)
Syncom Formulations (India) Ltd. is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is the main company-profile context available here, and it is enough to place Syncom Formulations (India) Share Price within its operating universe. Investors tracking Syncom Formulations (India) Company News often use sector and industry placement as the first filter before comparing valuation, market capitalisation and stock performance.
For readers who search Syncom Formulations (India) Share Price, Syncom Formulations (India) Share News or Syncom Formulations (India) Latest News, the company’s market context matters because it helps frame the current move within a recognised industry group. Univest keeps the focus on verified market data so that Syncom Formulations (India) Share Price can be read alongside the relevant sector and peer benchmarks.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Syncom Formulations (India) Share Price in the news today?
Ans. Syncom Formulations (India) Share Price is in the news because it rose 11.42% to Rs 22.35 and is trading close to its 52-week high. The latest price action is the main verified reason for attention.
What is Syncom Formulations (India) Share Price today?
Ans. Syncom Formulations (India) Share Price is Rs 22.35, compared with the previous close of Rs 20.06. That puts the stock higher by Rs 2.29 in the latest reading available for the session.
How close is Syncom Formulations (India) Share Price to its 52-week high?
Ans. Syncom Formulations (India) Share Price is trading near its 52-week high, with the day’s high at Rs 23.44. The price event remains a near-peak move rather than a new yearly high claim.
What does Syncom Formulations (India) Share Price say about valuation?
Ans. Syncom Formulations (India) Share Price sits with a P/E of 22.05 and a P/B of 4.29. Compared with the industry median P/E of 27.81, the valuation sits below the benchmark centre.
What are the key profitability ratios for Syncom Formulations (India) Share Price?
Ans. Syncom Formulations (India) Share Price is backed by ROE of 20.19% and ROCE of 26.8%. Both are above the sector medians shown in the healthcare industry snapshot, which adds context to the stock move.
How does Syncom Formulations (India) Share Price compare with peers?
Ans. Syncom Formulations (India) Share Price has a market capitalisation of Rs 1,885.64 crore, larger than Hester Biosciences and NGL Fine-Chem in the listed peer set. Its ROE and ROCE are also higher than those five peers.
What is the EPS linked to Syncom Formulations (India) Share Price?
Ans. Syncom Formulations (India) Share Price is associated with an EPS of 0.91 and a book value of Rs 4.68. EPS shows earnings per share, while book value shows accounting net worth per share.
Should investors track Syncom Formulations (India) Share Price on Univest?
Ans. Yes, Univest tracks Syncom Formulations (India) Share Price with live updates, 52-week levels, key ratios, sector data and stock news. That makes it easier to follow the latest share price update in one place.
Track Syncom Formulations (India) Share Price on Univest
Use Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Syncom Formulations (India) Share Price on Univest for live price updates, key ratios, 52-week levels, market capitalisation, company news and sector comparisons. The platform also helps users follow Syncom Formulations (India) Share Price Today, Syncom Formulations (India) Stock News and Syncom Formulations (India) Stock Analysis in one place. Univest continues to present the latest share price update in a format that is easy to read on mobile and search-friendly for quick market checks.